BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6307850)

  • 1. Humoral hypercalcemia caused by a rat Leydig-cell tumor is associated with suppressed parathyroid hormone secretion and increased urinary cAMP excretion.
    Spiegel AM; Saxe AW; Deftos LJ; Brennan MF
    Horm Metab Res; 1983 Jun; 15(6):299-304. PubMed ID: 6307850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normalization of hypercalcemia associated with a decrease in renal calcium reabsorption in Leydig cell tumor-bearing rats treated with WR-2721.
    Hirschel-Scholz S; Caverzasio J; Rizzoli R; Bonjour JP
    J Clin Invest; 1986 Jul; 78(1):319-22. PubMed ID: 3013941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of passive immunization against parathyroid hormone (PTH)-like peptide and PTH in hypercalcemic tumor-bearing rats and normocalcemic controls.
    Henderson J; Bernier S; D'Amour P; Goltzman D
    Endocrinology; 1990 Sep; 127(3):1310-8. PubMed ID: 2167215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphologic and functional studies of a rat hypercalcemia-associated testicular tumor maintained in cell culture.
    Saxe AW; Santora A; Norton J; Triche T; Brennan MF; Spiegel A
    Surgery; 1985 Dec; 98(6):1013-23. PubMed ID: 3000012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercalcemia and neoplasia. Biologic, biochemical, and ultrastructural studies of a hypercalcemia-producing Leydig cell tumor of the rat.
    Rice BF; Roth LM; Cole FE; MacPhee AA; Davis K; Ponthier RL; Sternberg WH
    Lab Invest; 1975 Oct; 33(4):428-39. PubMed ID: 52757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercalcemia in association with a Leydig cell tumor in the rat: a model for tumor-induced hypercalcemia in man.
    Berger ME; Golub MS; Sowers JR; Brickman AS; Nyby M; Troyer H; Rude RK; Singer FR; Horst R; Deftos LJ
    Life Sci; 1982 May; 30(18):1509-15. PubMed ID: 6281603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
    Haq M; Kremer R; Goltzman D; Rabbani SA
    J Clin Invest; 1993 Jun; 91(6):2416-22. PubMed ID: 8514854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone-like changes in renal calcium and phosphate reabsorption induced by Leydig cell tumor in thyroparathyroidectomized rats.
    Rizzoli R; Caverzasio J; Fleisch H; Bonjour JP
    Endocrinology; 1986 Sep; 119(3):1004-9. PubMed ID: 3755393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and histomorphometric characterization of a rat model for humoral hypercalcemia of malignancy.
    Insogna KL; Stewart AF; Vignery AM; Weir EC; Namnum PA; Baron RE; Kirkwood JM; Deftos LM; Broadus AE
    Endocrinology; 1984 Mar; 114(3):888-96. PubMed ID: 6546543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of calcium reabsorption observed in advanced breast cancer patients with hypercalcemia and multiple bone metastases.
    Kimura S; Adchi I; Yamaguchi K; Suzuki M; Shimada A; Sato Y; Nagaoka K; Abe K
    Jpn J Cancer Res; 1985 Apr; 76(4):308-14. PubMed ID: 2989061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of humoral hypercalcemia of malignancy in rats with inhibitors of carbonic anhydrase.
    Brown GM; Morris CA; Mitnick MA; Insogna KL
    J Bone Miner Res; 1990 Oct; 5(10):1037-41. PubMed ID: 1964358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of hypercalcemia in nude mice bearing a human renal carcinoma.
    Strewler GJ; Wronski TJ; Halloran BP; Miller SC; Leung SC; Williams RD; Nissenson RA
    Endocrinology; 1986 Jul; 119(1):303-10. PubMed ID: 3013591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pamidronate corrects the down-regulation of the renal parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor mRNA in rats bearing Walker tumors.
    Yaghoobian J; Morieux C; Denne MA; Bouizar Z; UreƱa P; de Vernejoul MC
    Horm Metab Res; 1998 May; 30(5):249-55. PubMed ID: 9660083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased production of tumor necrosis factor by normal immune cells in a model of the humoral hypercalcemia of malignancy.
    Sabatini M; Yates AJ; Garrett IR; Chavez J; Dunn JF; Bonewald L; Mundy GR
    Lab Invest; 1990 Nov; 63(5):676-82. PubMed ID: 2232714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A factor produced by cultured rat Leydig tumor (Rice 500) cells associated with humoral hypercalcemia stimulates adenosine 3',5'-monophosphate production via the parathyroid hormone receptor in human skin fibroblasts.
    Silve C; Santora A; Spiegel A
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1144-7. PubMed ID: 2987287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral hypercalcemia of malignancy in nude mouse model of a canine adenocarcinoma derived from apocrine glands of the anal sac. Biochemical, histomorphometric, and ultrastructural studies.
    Rosol TJ; Capen CC; Weisbrode SE; Horst RL
    Lab Invest; 1986 Jun; 54(6):679-88. PubMed ID: 3012199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of circulating parathyroid hormone-related protein in rats with humoral hypercalcemia of malignancy using a two-site immunoradiometric assay.
    Gaich G; Burtis WJ
    Endocrinology; 1990 Sep; 127(3):1444-9. PubMed ID: 2387260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoaciduria of vitamin D deficiency is independent of PTH levels and urinary cyclic AMP.
    Dabbagh S; Chesney R; Gusowski N; Mathews MC; Padilla M; Theissen M; Slatopolsky E
    Miner Electrolyte Metab; 1989; 15(4):221-32. PubMed ID: 2548072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of parathyroid hormone-related peptide production in vitro by the rat hypercalcemic Leydig cell tumor H-500.
    Liu B; Goltzman D; Rabbani SA
    Endocrinology; 1993 Apr; 132(4):1658-64. PubMed ID: 8462465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired production and decreased urinary excretion of adenosine 3',5'-monophosphate in primary hyperparathyroidism with vitamin D deficiency.
    Rubinger D; Friedlaender MM; Silver J; Wald H; Shumart T; Popovtzer MM
    Miner Electrolyte Metab; 1988; 14(5):283-7. PubMed ID: 2845240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.